LQDA
HealthcareLiquidia Corporation
$32.15
+$0.75 (+2.39%)
Jan 5, 2026
Price History (1Y)
Analysis
Liquidia Corporation is a biotechnology company operating in the healthcare sector with a market capitalization of $2.80 billion. The company has 170 employees and generates revenue of $69.22 million (TTM). Liquidia's industry classification is biotechnology. Financially, Liquidia reports significant losses with net income of -$124,092,000 (TTM) and EBITDA of -$106,044,000. However, the company maintains a gross margin of 89.1%. The balance sheet shows $157.50 million in cash and $199.18 million in debt, resulting in a debt to equity ratio of 903.24. Liquidia's valuation metrics include a forward P/E ratio of 13.65 and price to sales ratio of 40.41. The company's revenue growth has been substantial, with a year-over-year increase of 1121.7%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Liquidia Corporation
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
Visit website →Key Statistics
- Market Cap
- $2.80B
- P/E Ratio
- N/A
- 52-Week High
- $36.41
- 52-Week Low
- $11.26
- Avg Volume
- 1.95M
- Beta
- 0.49
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States
- Employees
- 170